Avantax Planning Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,571
Closed -$454K 324
2019
Q3
$454K Sell
4,571
-97
-2% -$9.22K 0.03% 180
2019
Q2
$435K Buy
4,668
+27
+0.6% +$2.56K 0.03% 188
2019
Q1
$438K Buy
+4,641
New +$406K 0.03% 178
2018
Q4
Sell
-2,436
Closed -$218K 1478
2018
Q3
$218K Buy
+2,436
New +$215K 0.02% 228
2018
Q2
Sell
-8,938
Closed -$797K 1883
2018
Q1
$797K Buy
8,938
+224
+3% +$21.5K 0.07% 116
2017
Q4
$909K Sell
8,714
-3,973
-31% -$448K 0.08% 107
2017
Q3
$1.85M Buy
12,687
+6,873
+118% +$936K 0.15% 68
2017
Q2
$755K Sell
5,814
-77
-1% -$9.44K 0.06% 141
2017
Q1
$733K Sell
5,891
-428
-7% -$51.2K 0.07% 141
2016
Q4
$731K Buy
+6,319
New +$704K 0.08% 125

Other funds holding CELG

Avantax Planning Partners's CELG Position: Q4 2019 in Review

Avantax Planning Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,571 shares — an estimated $454K sold.

Avantax Planning Partners first reported a position in CELG in Q4 2016 and held it in 10 quarters. The position peaked at $1.85M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Avantax Planning Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Avantax Planning Partners sold 4,571 Celgene Corp shares in Q4 2019, an estimated $454K.
  • Avantax Planning Partners first reported a position in Celgene Corp in Q4 2016 and held it in 10 quarters.
  • Avantax Planning Partners's Celgene Corp position peaked at $1.85M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Avantax Planning Partners's 13F filing for Q4 2019, filed 15 Jan 2020.